(S)-1-Boc-2-Methylpiperazine - CAS 169447-70-5
Catalog: |
BB012547 |
Product Name: |
(S)-1-Boc-2-Methylpiperazine |
CAS: |
169447-70-5 |
Synonyms: |
(2S)-2-methyl-1-piperazinecarboxylic acid tert-butyl ester; tert-butyl (2S)-2-methylpiperazine-1-carboxylate |
IUPAC Name: | tert-butyl (2S)-2-methylpiperazine-1-carboxylate |
Description: | Used in the preparation of pyrazolo[3,4-b]pyridine dual pharmacophores as PDE4-muscarinic antagonists. |
Molecular Weight: | 200.28 |
Molecular Formula: | C10H20N2O2 |
Canonical SMILES: | CC1CNCCN1C(=O)OC(C)(C)C |
InChI: | InChI=1S/C10H20N2O2/c1-8-7-11-5-6-12(8)9(13)14-10(2,3)4/h8,11H,5-7H2,1-4H3/t8-/m0/s1 |
InChI Key: | DATRVIMZZZVHMP-QMMMGPOBSA-N |
Boiling Point: | 268.74 °C at 760 mmHg |
Density: | 0.998 g/cm3 |
MDL: | MFCD01862121 |
LogP: | 1.48190 |
Publication Number | Title | Priority Date |
CN-111423454-A | Piperazine compound and application thereof in preparing chemokine receptor CCR2 antagonist | 20200424 |
CN-111423454-B | Piperazine compound and application thereof in preparing chemokine receptor CCR2 antagonist | 20200424 |
US-2021315896-A1 | Indazole based compounds and associated methods of use | 20200321 |
WO-2021194879-A1 | Indazole based compounds and associated methods of use | 20200321 |
US-2021299128-A1 | Compounds for treating or inhibiting recurrence of acute myeloid leukemia | 20200316 |
PMID | Publication Date | Title | Journal |
15755647 | 20050401 | Syntheses of quinolone hydrochloride enantiomers from synthons (R)- and (S)-2-methylpiperazine | Bioorganic & medicinal chemistry |
Complexity: | 211 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 200.152477885 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 200.152477885 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 41.6 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.9 |
-
Catalog: BB000557
((1-[(4-Methyl-1-piperazinyl)methyl]cyclopropyl)methyl)amine
Detail
-
Catalog: BB052624
(2-Fluorophenyl)-piperazin-1-ylmethanone 2,2,2-trifluoroacetic acid
Detail
-
Catalog: BB024422
(2S,6S)-2,6-Dimethylpiperazine
Detail
-
Catalog: BB018978
(3-Oxopiperazin-1-yl)acetic acid
Detail
-
Catalog: BB011156
(±)-trans-1-Allyl-2,5-dimethylpiperazine
Detail
-
Catalog: BB021304
(3S)-1-benzyl-3-(propan-2-yl)piperazine
Detail
-
Catalog: BB045251
(3,6-Dichlorobenzothiophen-2-yl)-piperazin-1-yl-methanone 2,2,2-trifluoroacetic acid
Detail
-
Catalog: BB078843
(2R,5R)-1,2,5-trimethylpiperazine dihydrochloride
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
-
[91054-33-0]
2-acetylbenzenecarbonitrile
-
[84030-20-6]
1,3,4,6,7,8-Hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine
-
[10374-51-3]
5-(Hydroxymethyl)dihydrofuran-2(3H)-one
-
[67210-36-0]
(R)-(+)-1,2-Epoxydecane
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[1415761-37-3]
5,8-Dibromo-1,3-diaza-2,6,7-trithia-2H-trindene
INDUSTRY LEADERS TRUST OUR PRODUCTS